Baker Bros. Advisors LP Edgewise Therapeutics, Inc. Put Options Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EWTX
# of Institutions
212Shares Held
101MCall Options Held
1.23MPut Options Held
416K-
Orbimed Advisors LLC San Diego, CA15MShares$391 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$232 Million3.85% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$157 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$130 Million10.85% of portfolio
-
Janus Henderson Group PLC London, X04.98MShares$130 Million0.07% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.64B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...